Related Experiment Video

Updated: Jul 27, 2025

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

26.8K

The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting

Sivan Izraely1, Shlomit Ben-Menachem1, Sapir Malka1

  • 1The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv 6997801, Israel.

Cells
|June 10, 2023
PubMed

Insights

Melanoma brain metastasis is fueled by communication between cancer cells and microglia. Targeting the IL-6/STAT3/SOCS3 pathway in microglia inhibits this process, offering a potential therapeutic strategy.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Immunology

Background:

  • Crosstalk between brain-metastasizing melanoma and microglia promotes metastasis.
  • Understanding the molecular mechanisms driving melanoma brain metastasis is crucial.

Purpose of the Study:

  • To investigate the molecular mechanisms of melanoma-microglia interactions in brain metastasis.
  • To elucidate how melanoma cells influence microglia to support metastasis progression.

Main Methods:

  • RNA-Sequencing, HTG miRNA whole transcriptome assay, and RPPA were used.
  • Analysis of four human brain-metastasizing melanoma cell lines and microglia interactions.
  • Investigated the role of IL-6, STAT3 phosphorylation, and SOCS3 expression.

Main Results:

  • Melanoma-derived IL-6 upregulates STAT3 phosphorylation and SOCS3 in microglia.
  • This IL-6/STAT3/SOCS3 pathway activation enhances melanoma cell viability, migration, and proliferation.
  • IL-6/STAT3 pathway inhibitors reduced microglial pro-metastatic functions and melanoma progression.

Conclusions:

  • Activation of the IL-6/STAT3/SOCS3 pathway in microglia is a key mechanism in melanoma brain metastasis.
  • Reciprocal melanoma-microglia signaling reinforces melanoma brain metastasis progression.
  • Melanoma heterogeneity influences microglia activation and response, suggesting personalized therapeutic approaches.
Keywords:
IL-6SOCS3STAT3brain metastasisinter-tumor heterogeneitymelanomamicroglia

More Related Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.4K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

938

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K